Bailing Out Pfizer Won’t Lower Drug Prices
A new agreement between the Trump administration and drug manufacturer Pfizer will exempt the giant from proposed pharmaceutical tariffs in
Read MoreA new agreement between the Trump administration and drug manufacturer Pfizer will exempt the giant from proposed pharmaceutical tariffs in
Read MoreAmid incoming pharmaceutical tariffs and an unprecedented deal between Pfizer and the White House, pharmacy industry and drug market experts
Read MoreAsahi Kasei, a provider in healthcare materials and technology, is launching two new specialty grades in its Sonanos portfolio. Paid
Read MoreDonald Trump Jr. allegedly stands to reap handsome profits from his dad’s radical overhaul of the way consumers purchase pharmaceutical
Read MoreThe pharmaceutical market has been in a fever for several months now. But in the last few weeks, the tension
Read MoreThe Trump administration has cut $500m worth of mRNA vaccine research funding, impacting around 22 projects being run at the
Read MoreIn a groundbreaking strategic pivot, pharmaceutical giant Pfizer (NYSE: PFE) is aggressively integrating artificial intelligence (AI), machine learning (ML), and
Read More(Bloomberg) — Pharmaceutical stocks are poised to cap off their best week in 16 years as a drug-pricing and tariff
Read MoreSofia’s deepening reliance on mandatory rebates shifts the healthcare deficit onto companies and jeopardises patients’ access to treatment, the pharmaceutical
Read More(WDNews) – Pfizer and President Donald Trump have struck a deal that reportedly would lower Medicaid drug prices to match
Read More